According to ProQR's latest financial reports the company's current EPS (TTM) is -$0.73. In 2022 the company made an earnings per share (EPS) of -$0.93 an increase over its 2021 EPS that were of -$1.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.73 | -20.82% |
2022 | -$0.93 | -17.82% |
2021 | -$1.13 | 5.65% |
2020 | -$1.07 | -29.79% |
2019 | -$1.52 | 20.59% |
2018 | -$1.26 | -36.38% |
2017 | -$1.98 | 6.62% |
2016 | -$1.86 | 87.35% |
2015 | -$0.99 | -8.61% |
2014 | -$1.09 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Atara Biotherapeutics ATRA | -$2.78 | 278.65% | ๐บ๐ธ USA |
Agenus
AGEN | -$0.85 | 15.77% | ๐บ๐ธ USA |
Actinium Pharmaceuticals ATNM | -$1.82 | 147.89% | ๐บ๐ธ USA |